Clinical trial
Post Authorization Registry Study of Patients Treated With LEQEMBI
NCT07762092 is registered in ClinicalTrials.gov with Eisai Limited as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Authorization Registry Study of Patients Treated With LEQEMBI
- Lead sponsor
- Eisai Limited
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- July 30, 2026
- Completion date
- April 1, 2036
- Enrollment
- 400 (estimated)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimers disease